Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre Life Science Investing
Cellceutix Nears Completion of Phase 2 Trial of New Oral Treatment for Psoriasis Life Science Investing
MedStar Announces First-of-Its-Kind Study Aimed at Evaluating Use of Less Invasive Procedure in Low Risk Patients with Diseased Heart Valves Biotech Investing
GeneOne Life Science Partners with Inovio Pharmaceuticals on Zika Virus Vaccine Development Pharmaceutical Investing
OncBioMune Receives Allowance for Patent Covering New Targeted Cancer Treatment Life Science Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
